RKLB
Rocket Lab USA, Inc.
RKLB lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
XOS
Xos, Inc.
There isn't enough reported data to score XOS yet.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
XOS Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Unavailable |
XOS's revenue, profitability and cash flow are currently weak. There isn't enough data to rate its balance sheet.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
XOS PE Valuation
XOS has no meaningful PE right now: it lost money over the past year.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
XOS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect XOS's losses to shrink, with revenue growing.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
XOS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.26 | +$2.03 |
| Q2 2026 | -$1.52 | +$4.31 |
| Q1 2026 | -$1.88 | +$4.27 |
| Q4 2025 | -$2.71 | +$3.98 |
| Q3 2025 | -$4.29 | +$2.37 |
| Q2 2025 | -$5.83 | +$1.91 |
| Q1 2025 | -$6.15 | +$4.56 |
| Q4 2024 | -$6.69 | +$6.42 |
XOS has the edge over RKLB on earnings, with more consistent year-over-year improvement.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over XOS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB has the edge over XOS on profitability, with a higher operating margin.
XOS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.5M | -66% |
| Q2 2026 | $4.7M | -74% |
| Q1 2026 | $11.2M | +91% |
| Q4 2025 | $5.2M | -55% |
| Q3 2025 | $16.5M | +4.5% |
| Q2 2025 | $18.4M | +18% |
| Q1 2025 | $5.9M | -55% |
| Q4 2024 | $11.5M | -38% |
XOS's revenue has slid since its 2025 peak: $6M last quarter, down 66% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -135% | -92 points |
| Q2 2026 | -168% | -129 points |
| Q1 2026 | -42% | +116 points |
| Q4 2025 | -187% | -60 points |
| Q3 2025 | -42% | +19 points |
| Q2 2025 | -39% | +35 points |
| Q1 2025 | -158% | -80 points |
| Q4 2024 | -127% | -63 points |
XOS's operating margin was −135% last quarter, down 92 points from the same quarter a year ago.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
XOS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.7M | -188% |
| Q2 2026 | -$2.7M | -158% |
| Q1 2026 | -$1.6M | +$3.1M |
| Q4 2025 | $2.4M | -27% |
| Q3 2025 | $3.1M | +$14.7M |
| Q2 2025 | $4.6M | +$30.8M |
| Q1 2025 | -$4.8M | +$9.9M |
| Q4 2024 | $3.3M | +$4.2M |
XOS has the edge over RKLB on cash flow, with more consistent year-over-year improvement.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has the edge over XOS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
XOS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +16% | +2M shares |
| 1 year | +76% | +6.3M shares |
| 3 years | +158% | +8.9M shares |
XOS has 15M diluted shares, up 76% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $3,000 |
| Q2 2020 | — |
| Q1 2020 | — |
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
XOS Net Leverage
XOS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
XOS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.3 | Neutral |
| Stochastic | 20.3 | Neutral |
XOS's weekly RSI is 45 (neutral) and its Stochastic is 20 (neutral).
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
XOS PE vs Industrials Sector
| Metric | XOS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
XOS has no meaningful PE right now: it lost money over the past year.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over XOS on trend strength, trading above more of its moving averages.
XOS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.76 | 17% below |
| 20 week MA | $2.68 | 15% below |
| 50 week MA | $2.43 | 5.8% below |
| 100 week MA | $2.83 | 19% below |
| 200 week MA | $6.50 | 65% below |
XOS is in a downtrend: it's below all five of its weekly moving averages, and 65% below its 200-week average.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.
XOS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $299.7 | $302.4 | +0.9% |
| 2021 | $302.4 | $91.5 | -70% |
| 2022 | $91.5 | $16.5 | -82% |
| 2023 | $16.5 | $7.98 | -52% |
| 2024 | $7.98 | $3.16 | -60% |
| 2025 | $3.16 | $2.02 | -36% |
| 2026 YTD | $2.02 | $2.29 | +13% |
XOS has the edge over RKLB on returns for 2026, with the stronger performance.